中文

智飞生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-28
ItemAmountY/Y
Revenue¥2.15B-8.6%
Gross profit¥0.63B
Operating income¥-0.44B
Net income¥-0.39B
Gross margin29.2%Net margin -18.3%
Revenue Q/Q+63.6%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥1.52B70.8%
R&D¥0.21B9.9%
SG&A¥0.38B17.9%
Tax & other¥-0.05B-2.2%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

汇川技术光线传媒阳光电源中际旭创晶盛机电天孚通信三环集团芒果超媒昆仑万维蓝思科技润泽科技先导智能

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies